Sleep Apnea Syndrome

Obtain overnight multichannel polysomnography (PSG) or a home sleep apnea test (HSAT) when the clinical history suggests sleep-disordered breathing. PSG records sleep and physiologic channels including electroencephalography, airflow, respiratory effort, oxygenation, electrocardiography, body position, and potentially carbon dioxide monitoring; it remains the reference diagnostic study. AHA Journals+1AHA JournalsObstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart AssociationNatureValidating a smart bed against polysomnography for sleep apnea detection | Scientific Reports

Interpret the AHI or REI in the clinical context. OSA is diagnosed with nocturnal breathing disturbances or unexplained daytime sleepiness/fatigue plus AHI/REI ≥5 events/hour; an AHI/REI ≥15 events/hour establishes OSA even without symptoms. Classify 5 to <15 as mild, 15-30 as moderate, and >30 events/hour as severe. AHA JournalsAHA JournalsObstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association

Use PSG rather than relying on a short-term screening technology when sleep staging, arousals, respiratory effort characterization, gas-exchange assessment, or differentiation from central sleep apnea is clinically important. HSAT is most useful in patients with high pretest probability of moderate-to-severe OSA; a non-diagnostic HSAT should not end evaluation when clinical suspicion remains high. AHA Journals+1AHA JournalsObstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart AssociationNatureValidating a smart bed against polysomnography for sleep apnea detection | Scientific Reports

Actively evaluate OSA in patients with cardiovascular disease, hypertension, heart failure, atrial fibrillation, coronary disease, or unexplained resistant cardiometabolic risk. OSA is associated with hypertension, cardiovascular disease, cognitive impairment, and metabolic abnormalities; recurrent upper-airway obstruction produces intermittent hypoxemia, hypercapnia, and sleep fragmentation. Annals of Internal Medicine+2Annals of Internal MedicineDiagnosis of Obstructive Sleep Apnea in Adults: A Clinical ...NatureObstructive sleep apnea -related hypertension: a review of the literature and clinical management strategy | Hypertension ResearchScienceDirectContinuous positive airway pressure versus mandibular advancement device in the treatment of obstructive sleep apnea: a systematic review and meta-analysis - ScienceDirect

In patients with atrial fibrillation, maintain a low threshold for OSA evaluation because OSA-associated intermittent hypoxia, negative intrathoracic pressure, atrial stretch, neurohumoral activation, and coexisting hypertension/metabolic disease promote atrial remodeling and an arrhythmogenic substrate. NatureNatureObstructive sleep apnea -related hypertension: a review of the literature and clinical management strategy | Hypertension Research

During preoperative assessment, identify known or suspected OSA and communicate it to anesthesia and surgical teams. OSA is associated with increased perioperative risk, and anesthesiology guidance supports routine preoperative screening; perioperative planning should account for the patient's established airway-pressure treatment and postoperative respiratory risk. Wolters KluwerWolters KluwerA Systemic Review of Obstructive Sleep Apnea and... : Anesthesia & Analgesia

Offer continuous positive airway pressure (CPAP) for moderate OSA and severe OSA unless a contraindication or inability to tolerate therapy redirects management. CPAP improves sleep measures compared with control or sham therapy in patients with AHI ≥15 events/hour and relieves upper-airway obstruction, hypoxemia, and hypercapnia. Annals of Internal Medicine+1Annals of Internal MedicineManagement of Obstructive Sleep Apnea in AdultsScienceDirectContinuous positive airway pressure versus mandibular advancement device in the treatment of obstructive sleep apnea: a systematic review and meta-analysis - ScienceDirect

At follow-up, obtain device data and address specific barriers rather than labeling a patient globally “nonadherent.” Review nightly use, residual respiratory events, mask leak, interface tolerance, and patient-reported sleepiness. Timely download review and targeted adjustments are identified as important steps for patients experiencing CPAP side effects. Oxford AcademicOxford AcademicPost-implant care pathway: lessons learned and recommendations after 5 years of clinical implementation of hypoglossal nerve stimulation therapy | SLEEP | Oxford Academic

Use adjunctive risk-factor measures alongside device therapy when relevant: weight loss and avoidance of alcohol or sedatives are emphasized in OSA management. These measures do not replace objective reassessment when symptoms persist or when treatment efficacy is uncertain. NatureNatureObstructive Sleep Apnea Diagnosis and Management | Respiratory Diseases | Cardiovascular Medicine and Haematology | Health sciences | Topics | Nature Index

Refer for hypoglossal nerve stimulation (HNS) evaluation when moderate-to-severe OSA remains clinically important and CPAP is not tolerated. Historical FDA approval criteria for Inspire included AHI 15-65 events/hour, predominantly obstructive events with central and mixed apneas <25% of total AHI, and BMI ≤32 kg/m². ScienceDirectScienceDirectHypoglossal Nerve Stimulator: A Novel Treatment Approach for OSA – Overview of Treatment, Including Diagnostic and Patient Criteria and Procedural Terminology Codes - ScienceDirect

HNS electrically activates upper-airway musculature through hypoglossal nerve stimulation, addressing tongue-base contribution to upper-airway collapse. Pooled patient-level data showed clinically significant improvement in OSA severity, daytime sleepiness, and sleep-related quality of life, but evidence for cardiovascular end points remains incomplete. JAMA+2JAMAEvaluation of Hypoglossal Nerve Stimulation Treatment in Obstructive Sleep ApneaScienceDirectPhysiology of hypoglossal nerve stimulationWolters KluwerUpper airway muscles: influence on obstructive...

Use a longitudinal implant pathway rather than judging outcome immediately after surgery. A reported standardized pathway activates the device approximately 4 weeks after implantation, allows 6-8 weeks for accommodation and adjustments, then performs objective sleep testing; in-laboratory PSG for efficacy assessment and setting refinement is commonly scheduled about 12 weeks after activation. Oxford AcademicOxford AcademicPost-implant care pathway: lessons learned and recommendations after 5 years of clinical implementation of hypoglossal nerve stimulation therapy | SLEEP | Oxford Academic

For CPAP, use device download data to evaluate actual use, residual events, and leak, then make targeted interface or treatment adjustments. For HNS, pair adherence and symptom assessment with post-activation sleep testing to determine whether programmed stimulation adequately reduces OSA. Oxford AcademicOxford AcademicPost-implant care pathway: lessons learned and recommendations after 5 years of clinical implementation of hypoglossal nerve stimulation therapy | SLEEP | Oxford Academic

When repeat testing is performed, interpret results with awareness of how the study was obtained. In HNS cohorts, 12-month AHI results have differed depending on whether testing used an untreated-setting sleep study versus a titration study segment at optimal stimulation parameters; efficacy testing should therefore be clinically interpretable and linked to the device settings used. JAMAJAMAEvaluation of Hypoglossal Nerve Stimulation Treatment in Obstructive Sleep Apnea

Continue management of associated cardiovascular disease and hypertension rather than assuming OSA therapy alone resolves risk. Severe untreated OSA has been associated with cardiovascular mortality in women, while adequate CPAP treatment may reduce that risk; causal cardiovascular benefit remains an area requiring patient-specific interpretation. Annals of Internal MedicineAnnals of Internal MedicineCardiovascular Mortality in Women With Obstructive Sleep ...